SIGA Technologies ( NASDAQ: SIGA ) on Wednesday announced a new contract with the U.S. Department of Defence for the procurement of about $9M of TPOXX.
The company added that the award was composed primarily of oral TPOXX, with a small amount of intravenous TPOXX, and represents the third procurement contract award from the DOD over the past three years. Inclusive of this award, SIGA currently has about $154M of outstanding oral and IV TPOXX orders. Press release.
More on SIGA Technologies SIGA Technologies: Poised For A Potential Windfall From Monkeypox Emergency Declaration SIGA Technologies: Shares Tanking On Mpox Study Miss, Turbulence May Be Temporary First mpox case outside Africa reported amid ongoing outbreak SIGA plunges as trial for mpox therapy fails in Africa.
